1-Methyl-3,5-diisopropoxybenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-Methyl-3,5-diisopropoxybenzene
• 英文别名: 1-methyl-3,5-di(propan-2-yloxy)benzene
• 化学式: C₁₃H₂₀O₂
• 分子量: 208.3
• InChiKey: IHEARZCPQSZIPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• PHOSPHORUS-CONTAINING CATALYSTS
  申请人：AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

  公开号：US20160207034A1

  公开（公告）日：2016-07-21

  The invention provides compounds of general structure I: (Ar 1 —Ar 2 —Ar 3 -E-P(=D)R 2 -) n M m X n L n ″. In this structure: •Ar 1 , Ar 2 and Ar 3 are aromatic groups wherein: —Ar 1 and Ar 3 are in a 1,3 relationship on Ar 2 , —each of Ar 1 , Ar 2 and Ar 3 optionally comprises one or more ring substituents of formula YR′ r wherein each Y independently is absent or is O, S, B, N or Si and each R′ is independently H, halogen, alkyl, cycloalkyl, aryl or heteroaryl and r is 1, 2 or 3, where r is 1 if Y is absent or is O or S, 2 if Y is B or N and 3 if Y is Si, —Ar 1 , Ar 2 and Ar 3 are each independently carbocyclic or heterocyclic and each is independently monocyclic, bicyclic or polycyclic and each ring of each of Ar 1 , Ar 2 and Ar 3 independently has 5, 6 or 7 ring atoms; •E is absent or is selected from the group consisting of O, S, NR″, SiR″ 2 , AsR″ 2 and CR″ 2 ; •M is a complexing metal; •X is selected from the group consisting of H, F, Br, CI, I, OTf, dba (dibenzylidene acetone), OC(═O)CF 3 and OAc; •L is selected from the group consisting of PR″ 2 , NR″ 2 , OR″, SR″, SiR″ 3 , AsR″ 3 , alkene, alkyne, aryl and heteroaryl, each of said alkene, alkyne, aryl and heteroaryl being optionally substituted, for example with one or more halogens and/or with one or more R groups as defined herein; •each R is independently alkyl, cycloalkyl, heterocyclyl, heterocycloalkyl, aryl or -, heteroaryl; •D is absent or is ═S or —O or —Z-linker-Z—, where each Z independently is O or NH or N-alkyl and linker is an alkyl chain of 2-5 carbon atoms in length; •each R″ is independently H, alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, each other than H being optionally substituted, or R″ 2 is —Z-linker-Z— as defined above; and •m is 0 or 1 or 2; wherein if m is 0, n is 1, n′ and n″ are 0 and -- is absent; and if m is 1 or 2, n is 1 or 2 and n′ and n″ are integers such that the coordination sphere of M is filled, and D is absent.

  该发明提供了一般结构I的化合物：（Ar1—Ar2—Ar3-E-P（=D）R2-）nMmXnLn″。在这个结构中： •Ar1，Ar2和Ar3是芳香族基团，其中：—Ar1和Ar3在Ar2上呈1,3关系，—Ar1，Ar2和Ar3中的每一个可选地包括一个或多个环取代基，其化学式为YR′r，其中每个Y独立地不存在或为O、S、B、N或Si，每个R′独立地为H、卤素、烷基、环烷基、芳基或杂芳基，r为1、2或3，其中如果Y不存在或为O或S，则r为1，如果Y为B或N，则r为2，如果Y为Si，则r为3，—Ar1，Ar2和Ar3分别独立地为碳环或杂环，每个分别独立地为单环、双环或多环，每个Ar1，Ar2和Ar3的每个环独立地具有5、6或7个环原子； •E不存在或从O、S、NR″、SiR″2、AsR″2和CR″2组成的群体中选择； •M是络合金属； •X从H、F、Br、Cl、I、OTf、dba（双苯亚乙酮）、OC（═O）CF3和OAc组成的群体中选择； •L从PR″2、NR″2、OR″、SR″、SiR″3、AsR″3、烯烃、炔烃、芳基和杂芳基组成的群体中选择，所述的每个烯烃、炔烃、芳基和杂芳基可选地被取代，例如用一个或多个卤素和/或如本文所定义的一个或多个R基取代； •每个R独立地为烷基、环烷基、杂环烷基、杂环烷基、芳基或-、杂芳基； •D不存在或为═S或—O或—Z-连接-Z—，其中每个Z独立地为O或NH或N-烷基，连接体为长度为2-5个碳原子的烷基链； •每个R″独立地为H、烷基、环烷基、杂环烷基、芳基或杂芳基，除H外的每个均可选地被取代，或R″2为—Z-连接-Z—如上所定义；和 •m为0或1或2；其中如果m为0，n为1，n′和n″为0且--不存在；如果m为1或2，n为1或2，n′和n″为整数，使得M的配位球填满，并且D不存在。
• Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative
  申请人：Murata Hiroko

  公开号：US20070149784A1

  公开（公告）日：2007-06-28

  An oxadiazole derivative represented by the following general formula (G1) is synthesized and applied to the light emitting element, wherein A m is a substituent represented by a general formula (Am1), (Am2), or (Am3); each of α, β 1 , and β 2 represents an arylene group having 6 to 25 carbon atoms; each of A r 1 to A r 6 represents an aryl group having 6 to 25 carbon atoms; each of R 1 to R 3 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, or an aryl group having 6 to 25 carbon atoms; and R 4 represents an alkyl group having 1 to 4 carbon atoms or an aryl group having 6 to 25 carbon atoms.

  由以下一般式（G1）表示的一种噁二唑衍生物被合成并应用于发光元件，其中Am是由一般式（Am1）、（Am2）或（Am3）表示的取代基；α、β1和β2分别表示具有6至25个碳原子的芳基基团；Ar1至Ar6分别表示具有6至25个碳原子的芳基基团；R1至R3分别表示氢、具有1至4个碳原子的烷基基团或具有6至25个碳原子的芳基基团；R4表示具有1至4个碳原子的烷基基团或具有6至25个碳原子的芳基基团。
• DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES
  申请人：Pierce C. Albert

  公开号：US20080014189A1

  公开（公告）日：2008-01-17

  The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及蛋白激酶抑制剂。该发明还提供了包含本发明化合物的药物组合物以及使用该组合物治疗各种疾病的方法。
• Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative
  申请人：Semiconductor Energy Laboratory Co., Ltd.

  公开号：US20140299822A1

  公开（公告）日：2014-10-09

  An oxadiazole derivative represented by the following general formula (G1) is synthesized and applied to the light emitting element, A m ; wherein A m is a substituent represented by a general formula (Am1), (Am2), or (Am3); each of α, β 1 , and β 2 represents an arylene group having 6 to 25 carbon atoms; each of A r 1 to A r 6 represents an aryl group having 6 to 25 carbon atoms; each of R 1 to R 3 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, or an aryl group having 6 to 25 carbon atoms; and R 4 represents an alkyl group having 1 to 4 carbon atoms or an aryl group having 6 to 25 carbon atoms.

  以下为一氧二唑衍生物的通式（G1），并应用于发光元件Am，其中Am是由通式（Am1）、（Am2）或（Am3）表示的取代基；α、β1和β2分别表示具有6至25个碳原子的芳基基团；Ar1至Ar6分别表示具有6至25个碳原子的芳基基团；R1至R3分别表示氢、具有1至4个碳原子的烷基基团或具有6至25个碳原子的芳基基团；R4表示具有1至4个碳原子的烷基基团或具有6至25个碳原子的芳基基团。
• Ruthenium-or osmium-based complex catalysts
  申请人：ARLANXEO DEUTSCHLAND GMBH

  公开号：US10441948B2

  公开（公告）日：2019-10-15

  The present invention relates to ruthenium- or osmium-based complex structures, to the synthesis thereof and their use as catalysts for hydrogenating unsaturated substrates.

  本发明涉及以钌或锇为基础的络合物结构、其合成及其作为氢化不饱和底物的催化剂的用途。